Main Article Content

Stephen Langley, MS, FRCS

Urologic cancers are an umbrella term for cancers of the prostate, kidney, bladder, penis, and testis. While cancers of the prostate, testes, and penis are specific to men, kidney cancer and bladder cancer affect both men and women. However, these also have a male-predominance, with men twice as likely to develop kidney and bladder cancer compared to women. The past 20 years have witnessed remarkable advances in the detection and management of urologic cancers. Routine use of advanced imaging modalities for various reasons has increased the detection of some of these cancers at an early stage. Robot-assisted surgery for nephrectomy, prostatectomy, cystectomy, and retroperitoneal lymph node dissection have improved surgical outcomes of localized disease. The introduction of targeted therapies since 2006 has revolutionized the management of metastatic kidney cancer. Despite these advances, the five-year survival of patients with advanced renal cancer is still poor, and we need a better understanding of the disease. The book Urologic Cancers provides an up-to date overview of a wide spectrum of topics that comprise epidemiological, pathological, clinical, and biological aspects of urologic cancers. From the epidemiological spectrum, the most recent information on the epidemiology of testicular cancer and penile cancer are presented. CONTINUE READING…..


Download data is not yet available.


Metrics Loading ...

Article Details